Iktorivil (Clonazepam)

Clonazepam enhances the activity of the neurotransmitter GABA by binding to a modulatory site on the GABA‑A receptor. This increases the opening of chloride channels, leading to greater neuronal inhibition, which helps suppress abnormal electrical activity in the brain responsible for seizures and reduces anxiety.

The dose of Iktorivil is individualized. A qualified prescriber determines the appropriate strength, frequency and duration based on the patient’s specific condition, age, renal and hepatic function, and response to therapy. No generic dosing regimen is provided here.

Clonazepam’s pregnancy category is not clearly defined, and potential risks to the fetus cannot be ruled out. It is generally advised to avoid use during pregnancy and lactation unless the therapeutic benefit justifies the potential risk, and this decision should be made by a healthcare professional.

To request Iktorivil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Iktorivil (clonazepam) shares the core mechanism of GABA‑A modulation with other benzodiazepines but is distinguished by a relatively long half‑life and strong anticonvulsant potency. Compared with agents such as diazepam or lorazepam, clonazepam may provide more sustained seizure control but also carries a similar risk of dependence.

Iktorivil tablets should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Iktorivil is administered orally, typically as a tablet that is swallowed whole with water. The exact route and timing are determined by the prescribing clinician, who may advise taking the medication with or without food based on individual tolerability.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, profound respiratory depression—especially when combined with other central nervous system depressants—and the emergence of depression or suicidal thoughts. Immediate medical attention is required if any of these events occur.

Iktorivil is contraindicated in patients with known hypersensitivity to clonazepam or other benzodiazepines, those with acute narrow‑angle glaucoma, and individuals who are currently intoxicated with alcohol or other CNS depressants. Caution is also advised for patients with severe hepatic impairment.